dostęp otwarty
COVID-19 — doświadczenia własne na przykładzie wybranych zachorowań w województwie pomorskim w okresie 1.03.2020–15.06.2020
Afiliacje- 1. Klinika Chorób Tropikalnych i Pasożytniczych. Instytut Medycyny Morskiej i Tropikalnej. Gdański Uniwersytet Medyczny. Uniwersyteckie Centrum Medycyny Morskiej i Tropikalnej, Gdynia
- 2. Zakład Diagnostyki Obrazowej, Uniwersyteckie Centrum Medycyny Morskiej i Tropikalnej, Gdynia
- 3. Pomorskie Centrum Chorób Zakaźnych i Gruźlicy, Gdańsk
dostęp otwarty
Streszczenie
Streszczenie
Słowa kluczowe
COVID-19, zachorowania, województwo pomorskie
Informacje o artykuleTytuł
COVID-19 — doświadczenia własne na przykładzie wybranych zachorowań w województwie pomorskim w okresie 1.03.2020–15.06.2020
Czasopismo
Numer
Typ artykułu
Artykuł redakcyjny
Strony
195-210
Opublikowany online
2020-10-29
Wyświetlenia strony
1779
Wyświetlenia/pobrania artykułu
115
Rekord bibliograficzny
Forum Medycyny Rodzinnej 2020;14(5):195-210.
Słowa kluczowe
COVID-19
zachorowania
województwo pomorskie
Autorzy
Katarzyna Sikorska
Natalia Zgud-Jankowska
Anna Susmarska
Arletta Chryścionko
Krzysztof Kędziora
Referencje (32)- Lu D. The hunt to find the coronavirus pandemic's patient zero. New Scientist. 2020; 245(3276): 9.
- https://www.who.int/news-room/detail/29-06-2020-covidtimeline. (19.09.2020).
- https://covid19.who.int/table. (19.09.2020).
- https://coronavirus.jhu.edu/data/mortality. (19.09.2020).
- https://stat.gov.pl/podstawowe-dane. (19.09.2020).
- http://www.wsse.katowice.pl/. (19.09.2020).
- Cheng HY, Jian SW, Liu DP, et al. Taiwan COVID-19 Outbreak Investigation Team. Contact Tracing Assessment of COVID-19 Transmission Dynamics in Taiwan and Risk at Different Exposure Periods Before and After Symptom Onset. JAMA Intern Med. 2020 [Epub ahead of print].
- Wei WE, Li Z, Chiew CJ, et al. Presymptomatic Transmission of SARS-CoV-2 - Singapore, January 23-March 16, 2020. MMWR Morb Mortal Wkly Rep. 2020; 69(14): 411–415.
- He Xi, Lau EHY, Wu P, et al. Author Correction: Temporal dynamics in viral shedding and transmissibility of COVID-19. Nat Med. 2020; 26(9): 1491–1493.
- https://www.ecdc.europa.eu/en/covid-19/latest-evidence/transmission/. (15.09.2020).
- Byambasuren O, Cardona M, Bell K, et al. Estimating the extent of asymptomatic COVID-19 and its potential for community transmission: systematic review and meta-analysis. MedRxiv . 2020.
- Wang W, Tang J, Wei F. Updated understanding of the outbreak of 2019 novel coronavirus (2019‐nCoV) in Wuhan, China. Journal of Medical Virology. 2020; 92(4): 441–447.
- Young S, Fernandez AP. Skin manifestations of COVID-19. Cleve Clin J Med. 2020 [Epub ahead of print].
- Varga Z, Flammer A, Steiger P, et al. Endothelial cell infection and endotheliitis in COVID-19. The Lancet. 2020; 395(10234): 1417–1418.
- Paniz‐Mondolfi A, Bryce C, Grimes Z, et al. Central nervous system involvement by severe acute respiratory syndrome coronavirus‐2 (SARS‐CoV‐2). Journal of Medical Virology. 2020; 92(7): 699–702.
- Becker RC. COVID-19-associated vasculitis and vasculopathy. J Thromb Thrombolysis. 2020; 50(3): 499–511.
- Lamers M, Beumer J, Vaart Jv, et al. SAR-CoV-2 productively infects human gut enterocytes. Science. 2020; 369(6499): 50–54.
- Gupta A, Madhavan M, Sehgal K, et al. Extrapulmonary manifestations of COVID-19. Nature Medicine. 2020; 26(7): 1017–1032.
- Guan W, Ni Z, Hu Y. Clinical characteristics of Coronavirus Disease 2019 in China. NEJM. 2020(382): 1708.
- Docherty AB, Harrison EM, Green CA, et al. ISARIC4C investigators. Features of 20 133 UK patients in hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: prospective observational cohort study. BMJ. 2020; 369: m1985.
- Richardson S, Hirsch JS, Narasimhan M, et al. the Northwell COVID-19 Research Consortium. Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area. JAMA. 2020; 323(20): 2052–2059.
- Wu Z, McGoogan JM. Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention. JAMA. 2020; 323(13): 1239–1242.
- www.cdc.gov/coronavirus/2019-ncov/covid-data/covid-net/purpose-methods. (19.09.2020).
- Yang X, Yu Y, Xu J, et al. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. The Lancet Respiratory Medicine. 2020; 8(5): 475–481.
- www.pteilchz.org.pl/informacje/rekomendacje. (19.09.2020).
- www.who.int/publications/m/item/targeted-update-safety-and-efficacy-of-hydroxychloroquine-or-chloroquine-for-treatment-of-covid-19 . (18.09.2020).
- NIH. COVID-19 Treatment Guidelines. Updated: May 12, 2020. American Society of Hematology. https://www.covid19treatmentguidelines.nih.gov (30.09.2020).
- Barlow H, Landolf KM, Barlow B, et al. Treatment of Coronavirus Disease 2019. Pharmacotherapy. 2020; 40(5): 416–437.
- McCreary, A, Pogue J. Coronavirus Disease 2019 Treatment: A Review of Early and Emerging Options. Open Forum Infect Dis. 2020(7): 105.
- Sanders JM, Monogue ML, Jodlowski T. Pharmacologic treatments for coronavirus disease 2019 (COVID-19): a review. JAMA. 2020; 323: 1824.
- www.covid19-druginteractions.org/checker. (19.09.2020).
